Abstract

5-Hydroxymethyl-2-furfurylamine (HMFA) is a key furan-based compound for manufacturing curing agents, additives, medicines and agrochemicals. It is also a good solvent for production of valuable biobased chemicals and biofuels. HMFA can be obtained by biological amination of 5-HMF by ω-transaminase (AT) from Aspergillus terreus. In this work, one stable triple mutant of AT ω-transaminase (HNILGD) was obtained via consensus mutagenesis. The half-life (t1/2) of the mutant AT ω-transaminase [G292D (glycine to aspartate), H210N (histidine to asparagine) I77L (isoleucine to leucine)] was 1.43- and 2.14-fold higher than that of the wild-type AT ω-transaminase at 35 °C and 50 °C, respectively. Recombinant E. coli containing HNILGD ω-transaminase could aminate high load of 5-HMF (800 mM) to HMFA in the aqueous media [HMFA yield 92 %, selectivity 100 %]. In deep eutectic solvent betaine:malonic acid (5 wt%), HNILGD cells converted 900 mM 5-HMF to HMFA with a yield of 97.4 %. Moreover, d-fructose was chemoenzymatically transformed to HMFA in the betaine:malonic acid − water. 36.0 g/L of d-fructose was dehydrated into 5-HMF (63.9 % yield) with betaine:malonic acid (5 wt%) at 180 °C for 1 h, and the formed 5-HMF was further aminated to HMFA by HNILGD cells with amine donor d-alanine (d-Ala-to-5-HMF molar ratio 16:1) at 35 °C and pH 8.0 after 24 h in betaine:malonic acid (5 wt%), obtaining a productivity of 0.433 g HMFA per g d-fructose [cal. 0.96 g HMFA/(g d-fructose-derived 5-HMF)]. A significant enhancement of HMFA production from biobased d-fructose-derived HMF by a robust triple mutant ω-transaminase biocatalyst was successfully developed in a betaine:malonic acid − water system.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call